معرفی
Clare Davenport is an active Clinical Associate Professor in the Institute of Applied Health Research within the Applied Health Sciences school at the University of Birmingham. With a prolific research career spanning over three decades since 1994, she has produced 105 research outputs and leads multiple significant projects funded by major UK research bodies including NIHR, MRC, and Cancer Research UK.
Her research interests center on diagnostic accuracy, systematic reviews, and medical testing methodologies, with particular expertise in ovarian cancer diagnosis, peripartum cardiomyopathy, skin cancer, and direct-to-consumer self-testing. Her work bridges clinical practice and methodological research, focusing on improving diagnostic pathways and decision-making in healthcare settings.
Analysis of her 15 most recent publications reveals a strong emphasis on evaluating diagnostic tools and risk prediction models, particularly in women's health and cancer diagnosis. Her research demonstrates consistent methodological rigor with frequent use of systematic reviews, meta-analyses, and large-scale cohort studies. Recent work has increasingly focused on the evaluation of direct-to-consumer testing in the UK healthcare context.
- CRUK DTCT (Cancer Research UK project, 2024-2025) - Principal Investigator
- NIHR BRC Theme - Data, Diagnostics & Decision Tools (2022-2027) - Researcher
- ROCkeTS Study (2014-2026) - Co-Investigator
- TEST Project (2020-2025) - Researcher
- APPEAL Programme (2016-2023) - Co-Investigator
Her research has garnered significant attention in both academic and public spheres, with several publications being widely covered by news outlets (one paper picked up by 160 news outlets) and discussed across social media platforms. This demonstrates the real-world impact and relevance of her work in shaping healthcare policy and practice.
